Sansure Biotech (SHSE:688289) Construction In Progress: ¥97 Mil (As of Mar. 2026)


SHSE:688289 Sansure Biotech Inc SHSE:688289
62 GF Score
Price ¥15.12
GF Value ¥20.64
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Sansure Biotech Construction In Progress?

Sansure Biotech SHSE:688289 +0.47% 62 Construction In Progress is ¥97 Mil as of Mar. 2026. GuruFocus rates SHSE:688289 with a GF Score™ of 62/100 and a GF Value™ of ¥20.64 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Sansure Biotech's quarterly construction in progress increased from Sep. 2025 (¥40 Mil) to Dec. 2025 (¥85 Mil) and increased from Dec. 2025 (¥85 Mil) to Mar. 2026 (¥97 Mil).

Sansure Biotech's annual construction in progress declined from Dec. 2023 (¥5 Mil) to Dec. 2024 (¥4 Mil) but then increased from Dec. 2024 (¥4 Mil) to Dec. 2025 (¥85 Mil).

Sansure Biotech Construction In Progress Historical Data

* Premium members only.

The historical data trend for Sansure Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sansure Biotech Construction In Progress Chart

Sansure Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 110.45 267.76 4.60 3.58 84.83

Sansure Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.94 24.77 39.85 84.83 96.65
SHSE:688289
62GF Score
Sansure Biotech Inc SHSE:688289
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sansure Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥97 Mil mean?
Sansure Biotech (SHSE:688289) has a Construction In Progress of ¥97 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Sansure Biotech and its competitors.
Is Sansure Biotech's Construction In Progress too high?
Sansure Biotech's current Construction In Progress is ¥97 Mil. Overall, Sansure Biotech has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sansure Biotech's Construction In Progress compare to ISRG and BDX?
Sansure Biotech's Construction In Progress of ¥97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Sansure Biotech and its competitors. Sansure Biotech's current Construction In Progress is ¥97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sansure Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sansure Biotech (SHSE:688289) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.64, compared to a current price of ¥15.12 — trading 26.7% below its estimated fair value. The current Construction In Progress is ¥97 Mil. Sansure Biotech's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Sansure Biotech (SHSE:688289), the current Construction In Progress is ¥97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sansure Biotech (SHSE:688289) Overvalued in 2026?

Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued. The current stock price of ¥15.12 is trading 26.7% below its estimated GF Value™ of ¥20.64. GuruFocus considers Sansure Biotech to be Modestly Undervalued.

Key valuation signals for SHSE:688289:

  • Construction In Progress: ¥97 Mil
  • GF Value™: ¥20.64 vs. price of ¥15.12 (26.7% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sansure Biotech Business Description

Address No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205
Sansure Biotech Inc is engaged in the Research, development, production, and sales of diagnostic reagents and instruments.
62GF Score

Get the complete analysis for SHSE:688289

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.12
Price
¥20.64
GF Value